Company
Headquarters: Khon Kaen, Thailand
CEO: Dr. Teerawat Srinakarin
฿3.22 Billion
THB as of July 1, 2024
US$87.7 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Ratchaphruek Hospital Public Company Limited engages in the hospital business under the Rachaphruek Hospital name in Thailand. The company provides medical services in the field of internal medicine, such as dermatology, neurology, hematology, pulmonary, rheumatology, gastroenterology, nephrology, and cardiology; general, urological, and colorectal surgeries; and pediatrics, orthopedics, otorhinolaryngology, ophthalmology, obstetrics and gynecology, check-up, dentistry, anesthesiology, emergency medical, rehabilitation, and diagnostic radiology. It also sells medicines and medical supplies. The company was formerly known as Sithan Karnpat Company Limited and changed its name to Ratchaphruek Hospital Public Company Limited in September 2016. Ratchaphruek Hospital Public Company Limited was incorporated in 1993 and is based in Khon Kaen, Thailand.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Ratchaphruek Hospital Public Company Ltd has the following listings and related stock indices.
Stock: SET: RPH wb_incandescent
Stock: SET: RPH.R wb_incandescent